FDA Finalizes NAC Enforcement Discretion Guidance

FDA issued final guidance regarding its decision to exercise enforcement discretion with respect to the sale and distribution of dietary supplements containing N-acetyl-L-cysteine (NAC). The final guidance is substantively identical to the draft guidance issued in April 2022. As we have previously reported, FDA concluded that NAC was excluded from the definition of a dietary... Continue Reading